Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027960 (
mole
)
21,279
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The benign dermal
nevus
can be transformed into malignant melanoma. The possibility that the transformation process is accompanied with enhanced casein kinase II (
CK II
) activity was investigated. The tissue samples were obtained by incisional biopsy, homogenized and ultracentrifuged. The supernatant was injected onto a Mono Q column.
CK II
was monitored with [gamma-32P]GTP and its specific substrate RRREEETEEE. The
CK II
stimulators, spermine and polylysine, the inhibitors heparin, quercetin, poly (Glu-Tyr) 4:1 and 2,3-bisphosphoglycerate were used for identification.
CK II
activity in metastatic melanoma samples was about 2.5-fold higher than in dermal
nevus
. These results support our hypothesis that
CK II
takes a central role in the non-transformed and transformed skin proliferation.
...
PMID:Enhanced casein kinase II activity in metastatic melanoma. 794 92